Structured follow-up after pulmonary embolism
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests a structured follow-up program for people who have had a pulmonary embolism. The program aims to help you recover better after your clot and lower the chance of future problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a pulmonary embolism (blood clot in the lung) confirmed by a CT scan.
- You live in Denmark.
- You do not have an active cancer diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how people do after an acute pulmonary embolism (a blood clot in the lungs). It aims to understand real-world outcomes over follow-up and may help improve how care teams track patients after treatment.
This trial studies a structured pulmonary (lung) rehabilitation program for people who still have breathing and activity problems after a pulmonary embolism (PE). It may help improve physical ability and function during recovery.
This study follows people who had a serious blood clot in their lungs that also affected their heart's right side. It tests how their ability to walk and move changes over 6 months, helping doctors understand recovery better.
This study tracks how patients do long-term after having a clot in the lung treated with a device called the Indigo Aspiration System. It aims to better understand safety and outcomes over time.
This study looks at whether pulmonary rehabilitation (a supervised exercise and support program for lung recovery) improves quality of life after a lung blood clot. It focuses on people who have ongoing breathing-related limits after treatment with blood thinners.
This study looks at whether a new way of grouping patients with blood clots in the lungs (pulmonary embolism) can better predict their outcomes. If you join, your health will be tracked for 30 days to see how well this new system works.
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.